ArticleCardiovascular and interventional radiology2025
Arterial Embolization of Joint Synovitis: The Latino Registry. Midterm Follow-Up of the Latino-Hip Cohort for Greater Trochanteric Pain Syndrome.
Article in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Multi-site efficacy and safety of transarterial microembolization with imipenem/cilastatin for refractory musculoskeletal pain: a single-centre analysis of hip, knee and shoulder (FIRE-NEM study).La Radiologia medica · 2026Article
- Periarticular Embolization as an Alternative Treatment for Surgery-Ineligible Patients with Hip Osteoarthritis: A Prospective Comparative Study.Journal of clinical medicine · 2026Article
- Hips Don't Lie-Hip Embolization for Pain Relief and Functional Improvement.Cardiovascular and interventional radiology · 2026Article
- HipE Study-Hip Embolization for Pain Control in Hip Osteoarthritis and Greater Trochanteric Pain Syndrome: 12 Months Follow-Up.Cardiovascular and interventional radiology · 2026Article
- Transarterial Embolization for the Treatment of Symptomatic Hip Osteoarthritis.Cardiovascular and interventional radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo present the midterm follow-up of a cohort of 31 patients with great trochanteric pain syndrome (GTPS) refractory to conservative management or physical therapy and no indication for surgery treated with embolization of the lateral femoral circumflex artery (LFCA). MATERIAL AND
methodsSingle-center prospective cohort from June 2019 to July 2023. This paper is an update of the initial experience with embolization of LFCA, previously published. Visual analog scale (VAS) was used to compare the symptoms before and after midterm follow-up. Technical success was considered when at least one artery responsible for the hyperemic synovium was embolized. Complications and adverse events were noted.
resultsThirty-one patients (38 joints) were included; mean age was 68.89 (+ 11.22) years. Thirty-six joints were treated with imipenem/cilastatin (I/C) alone, one with 100-300 μm BeadBlock and one using Microsphere 100-300 μm and I/C combined. 64.5% of the joints showed an association of GTPS with hip osteoarthritis on MRI pre-procedure. On the last FU 21 joints presented VAS 0 to 3, seven joints VAS 4 to 6 and nine did not feel any improvement, with VAS 7 to 10. One patient was lost to follow-up. Two patients present a minor complication (posterior tight numbness), spontaneously improved within 30 days.
conclusionLateral femoral circumflex artery embolization is feasible, and it is an alternative in pain reduction in patients with hip GTPS refractory to clinical treatment and no indication for surgery, in midterm follow-up.
Indexed as
Identifiers
39971796What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.